Advanced Health Intelligence (ASX:AHI) received a US patent for its technology used in assessing disease risks from user-captured images, according to a Jan. 10 filing with the Australian bourse.
The technology enables the analysis of user images to assess risks for metabolic, cardiovascular, and obesity-related diseases, providing users with a comprehensive risk assessment that can guide healthcare professionals in early diagnosis and intervention, the filing said.
The patent covers the process in which digital images, such as body shape and biometric data, are captured and analyzed to identify health risks.
The patent also provides exclusive protection for these methods, preventing third-party replication and reinforcing the company's competitive edge in the rapidly growing health tech sector, the filing said.
The digital health solutions provider plans to extend its patent coverage globally, with a focus on telehealth, population screening, and insurance, per the filing.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。